AnalystsPrakhar AgrawalPrakhar Agrawal's Stock Forecasts
AnalystsPrakhar Agrawal
Sectors:
Analyst Ranking
Top 15%
#829 out of 5511 analysts
Average Return
+19.44%
Win Rate
43%26 out of 61
Risk vs Reward
Poor
Good
Prakhar Agrawal's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Forma Therapeutics Holdings IncFMTX | +286.29% | $5.18 | $20.01 | 2022-06-13 - 2022-10-13 | Strong Buy |
Moonlake ImmunotherapeuticsMLTX | +257.29% | $17.63 | $62.99 | 2023-02-14 - 2024-02-13 | Strong Buy |
Metsera IncMTSR | +157.96% | $27.33 | $70.50 | 2025-02-25 - 2025-11-14 | Strong Buy |
Akero Therapeutics IncAKRO | +148.85% | $21.78 | $54.20 | 2024-06-20 - 2025-06-20 | Strong Buy |
Travere Therapeutics IncTVTX | +144.43% | $16.70 | $40.82 | 2025-04-23 - 2026-04-23 | Strong Buy |
Prakhar Agrawal Analyst Color
Get additional color on Prakhar Agrawal's coverage of popular stocks
Prakhar Agrawal's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Inventiva SaIVA | 1 | Strong Buy | N/A | N/A | Initiates Coverage On | 2 months ago |
Shattuck Labs IncSTTK | 1 | Strong Buy | N/A | N/A | Initiates Coverage On | 5 months ago |
Veradermics IncMANE | 1 | Strong Buy | N/A | N/A | Initiates Coverage On | 6 months ago |
Evommune IncEVMN | 1 | Strong Buy | N/A | N/A | Initiates Coverage On | 10 months ago |
Madrigal Pharmaceuticals IncMDGL | 5 | Strong Buy | N/A | N/A | Upgrades | 10 months ago |
Atyr Pharma IncATYR | 2 | Hold | N/A | N/A | Downgrades | a year ago |
Metsera IncMTSR | 2 | Strong Buy | N/A | N/A | Reiterates | a year ago |
Avalo Therapeutics IncAVTX | 1 | Strong Buy | N/A | N/A | Initiates Coverage On | a year ago |
Structure Therapeutics IncGPCR | 13 | Strong Buy | $65.00 | N/A | Reiterates | a year ago |
Oric Pharmaceuticals IncORIC | 7 | Strong Buy | N/A | N/A | Reiterates | a year ago |
Travere Therapeutics IncTVTX | 3 | Strong Buy | N/A | N/A | Reiterates | a year ago |
Aclaris Therapeutics IncACRS | 1 | Strong Buy | N/A | N/A | Reiterates | a year ago |
Keros Therapeutics IncKROS | 3 | Hold | N/A | N/A | Downgrades | 2 years ago |
Trisalus Life Sciences IncTLSI | 1 | Strong Buy | $10.00 | N/A | Initiates Coverage On | 2 years ago |
Moonlake ImmunotherapeuticsMLTX | 10 | Strong Buy | N/A | N/A | Reiterates | 2 years ago |
Akero Therapeutics IncAKRO | 5 | Strong Buy | N/A | N/A | Reiterates | 2 years ago |
Rapt Therapeutics IncRAPT | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Dice Therapeutics IncDICE2 | 2 | Hold | $48.00 | N/A | Downgrades | 3 years ago |
Tg Therapeutics IncTGTX | 2 | Strong Buy | $24.00 | N/A | Reiterates | 3 years ago |
Spectrum Pharmaceuticals IncSPPI | 1 | Hold | $0.75 | N/A | Maintains | 4 years ago |
Alaunos Therapeutics IncTCRT | 1 | Strong Buy | $450.00 | N/A | Assumes | 4 years ago |
Forma Therapeutics Holdings IncFMTX | 1 | Strong Buy | $21.00 | N/A | Assumes | 4 years ago |
Landos Biopharma IncLABP | 1 | Strong Buy | $390.00 | N/A | Initiates Coverage On | 5 years ago |
Cymabay Therapeutics IncCBAY | 1 | Strong Buy | $8.00 | N/A | Initiates Coverage On | 5 years ago |
Opus Genetics IncIRD | 1 | Strong Buy | $20.00 | N/A | Initiates Coverage On | 5 years ago |
Equillium IncEQ | 1 | Strong Buy | $14.00 | N/A | Initiates Coverage On | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.